USPTO Withdraws Proposed Rule Targeting
The USPTO is withdrawing the proposed new rule which was published in the Federal Register
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
